Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2019 Results
Teleconference and Webcast to be held on September 12, 2019 Sep 12, 2019, 07:30 ET CRANBURY, N.J., Sept. 12, 2019 /PRNewswire/ — Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems, whose product candidates are targeted, receptor-specific …
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2019 Results Read More »